Dr. Geschwind’s dedication to liver cancer treatment is evident in his role as a lead or co-investigator in more than 50 clinical trials. These trials have explored advanced methods such as intraarterial therapy using radioactive microspheres, a groundbreaking approach that delivers radiation directly to liver tumors. His work has provided new hope to patients with complex cancer diag... https://www.bumc.bu.edu/camed/jean-francois-jeff-geschwind-m-d-91-2011-distinguished-alumnus-award/